Cargando…

Regulation of Retroviral and SARS-CoV-2 Protease Dimerization and Activity through Reversible Oxidation

Most viruses encode their own proteases to carry out viral maturation and these often require dimerization for activity. Studies on human immunodeficiency virus type 1 (HIV-1), type 2 (HIV-2) and human T-cell leukemia virus (HTLV-1) proteases have shown that the activity of these proteases can be re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, David A., Bulut, Haydar, Shrestha, Prabha, Mitsuya, Hiroaki, Yarchoan, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598996/ https://www.ncbi.nlm.nih.gov/pubmed/36290777 http://dx.doi.org/10.3390/antiox11102054

Ejemplares similares

Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300
por: Davis, David A., et al.
Publicado: (2021)

Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300
por: Davis, David A., et al.
Publicado: (2021)

A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication
por: Hattori, Shin-ichiro, et al.
Publicado: (2021)

GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection
por: Hattori, Shin-ichiro, et al.
Publicado: (2020)

Potent and biostable inhibitors of the main protease of SARS-CoV-2
por: Tsuji, Kohei, et al.
Publicado: (2022)

Retroviral proteases
por: Dunn, Ben M, et al.
Publicado: (2002)

Single atom changes in newly synthesized HIV protease inhibitors reveal structural basis for extreme affinity, high genetic barrier, and adaptation to the HIV protease plasticity
por: Bulut, Haydar, et al.
Publicado: (2020)

Computational fragment screening of dimeric SARS-CoV-2 main protease
por: Reid, Rashad L., et al.
Publicado: (2023)

Dimer Interface Organization is a Main Determinant of Intermonomeric Interactions and Correlates with Evolutionary Relationships of Retroviral and Retroviral-Like Ddi1 and Ddi2 Proteases
por: Mótyán, János András, et al.
Publicado: (2020)

Maturation of the SARS-CoV-2 virus is regulated by dimerization of its main protease
por: Kaptan, Shreyas, et al.
Publicado: (2022)

Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA
por: Bello, Martiniano, et al.
Publicado: (2020)

Retroviral RNA Dimerization: From Structure to Functions
por: Dubois, Noé, et al.
Publicado: (2018)

Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir
por: Paciaroni, Alessandro, et al.
Publicado: (2023)

Amino-acid inserts of HIV-1 capsid (CA) induce CA degradation and abrogate viral infectivity: Insights for the dynamics and mechanisms of HIV-1 CA decomposition
por: Amano, Masayuki, et al.
Publicado: (2019)

The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors
por: Silvestrini, Lucia, et al.
Publicado: (2021)

Comparative Studies on Retroviral Proteases: Substrate Specificity
por: Tözsér, József
Publicado: (2010)

Restoration of immune surface molecules in Kaposi sarcoma-associated herpes virus infected cells by lenalidomide and pomalidomide
por: Davis, David A., et al.
Publicado: (2017)

A Look Inside HIV Resistance through Retroviral Protease Interaction Maps
por: Kontijevskis, Aleksejs, et al.
Publicado: (2007)

Crystal Structure of a Retroviral Polyprotein: Prototype Foamy Virus Protease-Reverse Transcriptase (PR-RT)
por: Harrison, Jerry Joe E. K., et al.
Publicado: (2021)

Drug binding dynamics of the dimeric SARS-CoV-2 main protease, determined by molecular dynamics simulation
por: Komatsu, Teruhisa S., et al.
Publicado: (2020)

Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2
por: Shrestha, Prabha, et al.
Publicado: (2021)

A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency
por: Aoki, Manabu, et al.
Publicado: (2017)

Deciphering the targets of retroviral protease inhibitors in Plasmodium berghei
por: Onchieku, Noah Machuki, et al.
Publicado: (2018)

Natural Polyphenols Inhibit the Dimerization of the SARS-CoV-2 Main Protease: The Case of Fortunellin and Its Structural Analogs
por: Panagiotopoulos, Athanasios A., et al.
Publicado: (2021)

Key dimer interface residues impact the catalytic activity of 3CLpro, the main protease of SARS-CoV-2
por: Ferreira, Juliana C., et al.
Publicado: (2022)

A Structural Comparison of SARS-CoV-2 Main Protease and Animal Coronaviral Main Protease Reveals Species-Specific Ligand Binding and Dimerization Mechanism
por: Ho, Chien-Yi, et al.
Publicado: (2022)

Retroviral RNA Dimerization and Packaging: The What, How, When, Where, and Why
por: Johnson, Silas F., et al.
Publicado: (2010)

C-terminal domain of SARS-CoV main protease can form a 3D domain-swapped dimer
por: Zhong, Nan, et al.
Publicado: (2009)

The N-terminal peptide of the main protease of SARS-CoV-2, targeting dimer interface, inhibits its proteolytic activity
por: Song, Sunyu, et al.
Publicado: (2023)

Implications of the Nucleocapsid and the Microenvironment in Retroviral Reverse Transcription
por: Mougel, Marylène, et al.
Publicado: (2010)

The retroviral RNA dimer linkage: different structures may reflect different roles
por: Greatorex, Jane
Publicado: (2004)

Retroviral-like determinants and functions required for dimerization of Ty1 retrotransposon RNA
por: Gumna, Julita, et al.
Publicado: (2019)

Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode
por: Chen, Shuai, et al.
Publicado: (2010)

Non-Toxic Dimeric Peptides Derived from the Bothropstoxin-I Are Potent SARS-CoV-2 and Papain-like Protease Inhibitors
por: Freire, Marjorie C. L. C., et al.
Publicado: (2021)

Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor
por: Nashed, Nashaat T., et al.
Publicado: (2022)

Enhancement of SARS-CoV Infection by Proteases
por: Matsuyama, Shutoku, et al.
Publicado: (2006)

Chloropyridinyl Esters of Nonsteroidal Anti-Inflammatory Agents and Related Derivatives as Potent SARS-CoV-2 3CL Protease Inhibitors
por: Ghosh, Arun K., et al.
Publicado: (2021)

Asymmetric dynamics of dimeric SARS-CoV-2 and SARS-CoV main proteases in an apo form: Molecular dynamics study on fluctuations of active site, catalytic dyad, and hydration water
por: Iida, Shinji, et al.
Publicado: (2021)

A dimeric proteomimetic prevents SARS-CoV-2 infection by dimerizing the spike protein
por: Khatri, Bhavesh, et al.
Publicado: (2022)

High-resolution structure of a retroviral protease folded as a monomer
por: Gilski, Miroslaw, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_491stt3inna864g6qd4tfetorv